Corrigendum: ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics

Corrigendum: ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics

Bibliographic Details
Main Authors:	Nikola Kurbatfinski, Cameron N. Kramer, Steven D. Goodman, Lauren O. Bakaletz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Microbiology
Subjects:	AMR MRSA humanized monoclonal antibody DNABII proteins tip-chimer peptide
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1382491/full

Similar Items

ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics
by: Nikola Kurbatfinski, et al.
Published: (2023-07-01)

Disruption of nontuberculous mycobacteria biofilms induces a highly vulnerable to antibiotic killing phenotype
by: Nikola Kurbatfinski, et al.
Published: (2023-12-01)

Immunization with a Biofilm-Disrupting Nontypeable <italic toggle="yes">Haemophilus influenzae</italic> Vaccine Antigen Did Not Alter the Gut Microbiome in Chinchillas, Unlike Oral Delivery of a Broad-Spectrum Antibiotic Commonly Used for Otitis Media
by: Michael T. Bailey, et al.
Published: (2020-04-01)

Bacterial Biofilms Utilize an Underlying Extracellular DNA Matrix Structure That Can Be Targeted for Biofilm Resolution
by: Steven D. Goodman, et al.
Published: (2022-02-01)

Epigenetic Regulation Alters Biofilm Architecture and Composition in Multiple Clinical Isolates of Nontypeable <named-content content-type="genus-species">Haemophilus influenzae</named-content>
by: Kenneth L. Brockman, et al.
Published: (2018-11-01)

Nontypeable Haemophilus influenzae released from biofilm residence by monoclonal antibody directed against a biofilm matrix component display a vulnerable phenotype
by: Kathryn Q. Wilbanks, et al.
Published: (2023-08-01)

Monoclonal antibodies that target extracellular DNABII proteins or the type IV pilus of nontypeable Haemophilus influenzae (NTHI) worked additively to disrupt 2-genera biofilms
by: Joseph A. Jurcisek, et al.
Published: (2022-12-01)

Oral and middle ear delivery of otitis media standard of care antibiotics, but not biofilm-targeted antibodies, alter chinchilla nasopharyngeal and fecal microbiomes
by: Audrey F. Duff, et al.
Published: (2024-02-01)

Corrigendum: A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis
by: Wenyan Fu, et al.
Published: (2021-12-01)

Healing wounds, defeating biofilms: Lactiplantibacillus plantarum in tackling MRSA infections
by: Ashish Kumar Dubey, et al.
Published: (2023-12-01)

Editorial: Women in biofilms 2021
by: Carina Almeida, et al.
Published: (2022-10-01)

Crumbling the Castle: Targeting DNABII Proteins for Collapsing Bacterial Biofilms as a Therapeutic Approach to Treat Disease and Combat Antimicrobial Resistance
by: James V. Rogers, et al.
Published: (2022-01-01)

Nontypeable Haemophilus influenzae newly released (NRel) from biofilms by antibody-mediated dispersal versus antibody-mediated disruption are phenotypically distinct
by: Elaine M. Mokrzan, et al.
Published: (2020-12-01)

Genomic characterization of two community-acquired methicillin-resistant Staphylococcus aureus with novel sequence types in Kenya
by: John Njenga, et al.
Published: (2022-09-01)

Structural stability of Burkholderia cenocepacia biofilms is reliant on eDNA structure and presence of a bacterial nucleic acid binding protein.
by: Laura A Novotny, et al.
Published: (2013-01-01)

Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer
by: Ke-Tao Jin, et al.
Published: (2021-02-01)

Haemophilus influenzae and oxidative stress
by: Alistair eHarrison, et al.
Published: (2012-03-01)

Genetic mechanisms and correlated risk factors of antimicrobial-resistant ESKAPEE pathogens isolated in a tertiary hospital in Malaysia
by: Soo Tein Ngoi, et al.
Published: (2021-04-01)

Antibiotic Sensitivity to Methicillin and Methicillin Plus Macrolide- Lincosamide-Streptogramins Resistant Staphylococcus Aureus
by: Hamzullah Khan, et al.
Published: (2021-03-01)

Antimicrobial Resistance Patterns in Diabetic Foot Infections, an Epidemiological Study in Northeastern Italy
by: Giovanni Boschetti, et al.
Published: (2021-10-01)

Microbiome-Independent Effects of Antibiotics in a Murine Model of Nosocomial Infections
by: Keenan A. Lacey, et al.
Published: (2022-06-01)

Current trends in monoclonal antibody development and manufacturing /
by: Shire, Steven J.
Published: (2010)

B cell depletion therapies in autoimmune diseases: Monoclonal antibodies or chimeric antigen receptor-based therapy?
by: Zheng Zhang, et al.
Published: (2023-02-01)

mSphere of Influence: Targeting bacterial signaling and metabolism to overcome antimicrobial resistance
by: Merve S. Zeden
Published: (2024-02-01)

Methicillin Resistant Staphylococcus aureus: Molecular Mechanisms Underlying Drug Resistance Development and Novel Strategies to Combat
by: Abebe AA, et al.
Published: (2023-12-01)

The Hidden Cost of COVID-19: Focus on Antimicrobial Resistance in Bloodstream Infections
by: Giulia Micheli, et al.
Published: (2023-05-01)

Hybridoma technology; advancements, clinical significance, and future aspects
by: Sanchita Mitra, et al.
Published: (2021-10-01)

The functionality of a therapeutic antibody candidate restored by a single mutation from proline to threonine in the variable region
by: Marie Hautiere, et al.
Published: (2023-12-01)

Quality microbiological diagnostics and antimicrobial susceptibility testing, an essential component of antimicrobial resistance surveillance and control efforts in Pacific island nations
by: John Kenneth Ferguson, et al.
Published: (2020-03-01)

Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies
by: Paola Storti, et al.
Published: (2020-09-01)

The Use of Chimeric Virus-like Particles Harbouring a Segment of Hantavirus Gc Glycoprotein to Generate a Broadly-Reactive Hantavirus-Specific Monoclonal Antibody
by: Aurelija Zvirbliene, et al.
Published: (2014-02-01)

Monoclonal antibodies : the second generation /
by: 186276 Zola, Heddy
Published: (1995)

Monoclonal antibodies /
by: Peter, J. H., et al.
Published: (1992)

Large-scale production of monoclonal antibodies in suspension culture /
by: 271860 Backer, M. P., et al.

Molecular Characterization of Community- and Hospital- Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> Isolates during COVID-19 Pandemic
by: Muhammad Sohail, et al.
Published: (2023-01-01)

How can we fight against antimicrobial-resistant bacteria in the World Health Organization Western Pacific Region?
by: Yoshiaki Gu, et al.
Published: (2012-07-01)

The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway.
by: Glen McGillivary, et al.
Published: (2010-10-01)

Monoclonal antibodies : principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry and immunology /
by: 250151 Goding, James W.
Published: (1996)

Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An <i>In Silico</i> Investigation
by: Nabarun Chandra Das, et al.
Published: (2023-02-01)

MANUFACTURING OF HYBRIDOMAS-PRODUCERS OF MONOCLONAL ANTIBODIES TO BRUCELLOSIS AGENT ANTIGENS
by: G. V. Kuklina, et al.
Published: (2017-06-01)